Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detecti... ( FREMONT Calif. July 1 /- Microflu...)

HOME >> BIOLOGY >> TECHNOLOGY

Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems

Date:7/1/2008

FREMONT, Calif., July 1 /PRNewswire/ -- Microfluidic Systems Inc. (MFSI) announced today that it has been awarded the Phase 3X agreement for the production of Microfluidic - Bioagent Autonomous Networked Detector (M-BAND). This award is the fourth in a series of funded phases by the DHS Science and Technology Directorate since 2003. The continued funding through March 2009, will allow for low-volume production of automated systems for extended field trials in key locations around the US. Included in the continued funding is an option to purchase, deploy and support additional instruments for the field during the period from April 2009 through September 2009. These new systems to be deployed are intended to improve the detection of biological pathogens that could contaminate the population in a city or large metropolitan area.

The US Department of Homeland Security's Science and Technology Directorate has been funding this effort dedicated to monitoring air quality, particularly focused on biosecurity threats, such as those listed on the A and B lists of the Centers for Disease Control (CDC).

MFSI is the prime contractor receiving this funding to develop an improved, cost-effective autonomous airborne pathogen detection and identification system. As announced on Feb. 25, 2008, MFSI has teamed up with Applied Biosystems and United Technologies, Hamilton Sundstrand Division, to incorporate proven technologies into the Microfluidics-based Bioagent Autonomous Networked Detector (M-BAND) and ensure service and support from these two world-class corporations. Applied Biosystems, based in Foster City, Calif., is a global leader in the development and commercialization of instrument-based systems, consumables, software and services for the life science market and is expected to provide the manufacturing of TaqMan(R) Real-time PCR pathogen assays, which are chemistry reagents that detect harmful pathogens. Hamilton Sundstrand based in Pomona, Calif., is a
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. febit Receives U.S. Patent for Microfluidic Extraction Method
2. Microchip Biotechnologies, Inc. Enters Into License Arrangement With GE Healthcare for Fundamental Microfluidic Patents
3. Microfluidic Systems to Show Automated Biological Agent Detection Technology to U.S. House of Representatives
4. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
5. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
6. Microfluidic chambers advance the science of growing neurons
7. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
8. Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise
9. Cellumen to Collaborate With the NCTR of the FDA to Apply Cellular Systems Biology (CSB(TM)) to Predictive Toxicology
10. Impact Systems Announces Completion of Successful Enterprise Content Migrations to Documentum 6
11. TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment

Post Your Comments:

Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detecti...( FREMONT Calif. July 1 /- Microflu...)